Intraocular Melanoma Treatment Market is witnessing growing interest from healthcare researchers and pharmaceutical companies because of the need for more effective therapies for rare eye cancers. Uveal melanoma is uncommon, but it is the most common primary intraocular malignancy in adults. The treatment environment has traditionally relied heavily on local approaches such as radiation and...